Elbeik T - Search Results

1

Health care industries' perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assay.

Elbeik T, Loftus RA, Beringer S. Elbeik T, et al. Expert Rev Mol Diagn. 2002 May;2(3):275-85. doi: 10.1586/14737159.2.3.275. Expert Rev Mol Diagn. 2002. PMID: 12050866

2

Simultaneous runs of the Bayer VERSANT HIV-1 version 3.0 and HCV bDNA version 3.0 quantitative assays on the system 340 platform provide reliable quantitation and improved work flow.

Elbeik T, Markowitz N, Nassos P, Kumar U, Beringer S, Haller B, Ng V. Elbeik T, et al. J Clin Microbiol. 2004 Jul;42(7):3120-7. doi: 10.1128/JCM.42.7.3120-3127.2004. J Clin Microbiol. 2004. PMID: 15243070 Free PMC article.

3

Cost assessment of the automated VERSANT 440 Molecular System versus the semi-automated System 340 bDNA Analyzer platforms.

Elbeik T, Loftus RA, Beringer S. Elbeik T, et al. Expert Rev Mol Diagn. 2007 Nov;7(6):713-22. doi: 10.1586/14737159.7.6.713. Expert Rev Mol Diagn. 2007. PMID: 18020902

4

HIV-1 and HCV viral load cost models for bDNA: 440 Molecular System versus real-time PCR AmpliPrep/TaqMan test.

Elbeik T, Dalessandro R, Loftus RA, Beringer S. Elbeik T, et al. Expert Rev Mol Diagn. 2007 Nov;7(6):723-53. doi: 10.1586/14737159.7.6.723. Expert Rev Mol Diagn. 2007. PMID: 18020903

5

Global cost modeling analysis of HIV-1 and HCV viral load assays.

Elbeik T, Chen YM, Soutchkov SV, Loftus RA, Beringer S. Elbeik T, et al. Expert Rev Pharmacoecon Outcomes Res. 2003 Aug;3(4):383-407. doi: 10.1586/14737167.3.4.383. Expert Rev Pharmacoecon Outcomes Res. 2003. PMID: 19807450

6

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.

Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM. Deeks SG, et al. Among authors: elbeik t. AIDS. 1999 Apr 16;13(6):F35-43. doi: 10.1097/00002030-199904160-00001. AIDS. 1999. PMID: 10397555

7

Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5.

Elbeik T, Alvord WG, Trichavaroj R, de Souza M, Dewar R, Brown A, Chernoff D, Michael NL, Nassos P, Hadley K, Ng VL. Elbeik T, et al. J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):330-9. doi: 10.1097/00126334-200204010-00002. J Acquir Immune Defic Syndr. 2002. PMID: 11917236

8

Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.

Elbeik T, Charlebois E, Nassos P, Kahn J, Hecht FM, Yajko D, Ng V, Hadley K. Elbeik T, et al. J Clin Microbiol. 2000 Mar;38(3):1113-20. doi: 10.1128/JCM.38.3.1113-1120.2000. J Clin Microbiol. 2000. PMID: 10699005 Free PMC article.

9

Evaluation of the VACUTAINER PPT Plasma Preparation Tube for use with the Bayer VERSANT assay for quantification of human immunodeficiency virus type 1 RNA.

Elbeik T, Nassos P, Kipnis P, Haller B, Ng VL. Elbeik T, et al. J Clin Microbiol. 2005 Aug;43(8):3769-71. doi: 10.1128/JCM.43.8.3769-3771.2005. J Clin Microbiol. 2005. PMID: 16081908 Free PMC article.

10

Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA).

Elbeik T, Surtihadi J, Destree M, Gorlin J, Holodniy M, Jortani SA, Kuramoto K, Ng V, Valdes R Jr, Valsamakis A, Terrault NA. Elbeik T, et al. J Clin Microbiol. 2004 Feb;42(2):563-9. doi: 10.1128/JCM.42.2.563-569.2004. J Clin Microbiol. 2004. PMID: 14766817 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters